Get started
HCW Biologics Inc.HCW Biologics Inc.HCW Biologics Inc.

HCW Biologics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

HCWB chart


Full chart

HCWB upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪15.05 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.0045 USD
Net income (FY)
‪−24.99 M‬ USD
Revenue (FY)
‪2.84 M‬ USD
Shares float
‪19.75 M‬
Beta (1Y)
−1.04

Employees


Employees (FY)
45
Change (1Y)
+1 +2.27%
Revenue / Employee (1Y)
‪63.15 K‬ USD
Net income / Employee (1Y)
‪−555.43 K‬ USD

About HCW Biologics Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Hing C. Wong
Website
hcwbiologics.com
Headquarters
Miramar
Founded
2018
FIGI
BBG011769443
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HCWB news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HCWB is 0.3980 USD — it has decreased by −0.20% in the past 24 hours. Watch HCW Biologics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HCW Biologics Inc. stocks are traded under the ticker HCWB.
HCWB stock has risen by 2.58% compared to the previous week, the month change is a −43.14% fall, over the last year HCW Biologics Inc. has showed a −64.46% decrease.
We've gathered analysts' opinions on HCW Biologics Inc. future price: according to them, HCWB price has a max estimate of 3.00 USD and a min estimate of 3.00 USD. Watch HCWB chart and read a more detailed HCW Biologics Inc. stock forecast: see what analysts think of HCW Biologics Inc. and suggest that you do with its stocks.
HCWB reached its all-time high on Jul 20, 2021 with the price of 7.7750 USD, and its all-time low was 0.2761 USD and was reached on Nov 14, 2024. View more price dynamics on HCWB chart.
See other stocks reaching their highest and lowest prices.
HCWB stock is 10.86% volatile and has beta coefficient of −1.04. Track HCW Biologics Inc. stock price on the chart and check out the list of the most volatile stocks — is HCW Biologics Inc. there?
Today HCW Biologics Inc. has the market capitalization of ‪15.05 M‬, it has increased by 20.41% over the last week.
Yes, you can track HCW Biologics Inc. financials in yearly and quarterly reports right on TradingView.
HCW Biologics Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
HCWB earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.13 USD resulting in a 23.08% surprise. The estimated earnings for the next quarter are 0.09 USD per share. See more details about HCW Biologics Inc. earnings.
HCWB net income for the last quarter is ‪−3.90 M‬ USD, while the quarter before that showed ‪−15.28 M‬ USD of net income which accounts for 74.46% change. Track more HCW Biologics Inc. financial stats to get the full picture.
No, HCWB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 45.00 employees. See our rating of the largest employees — is HCW Biologics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HCW Biologics Inc. EBITDA is ‪−23.67 M‬ USD, and current EBITDA margin is −865.02%. See more stats in HCW Biologics Inc. financial statements.
Like other stocks, HCWB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HCW Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HCW Biologics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HCW Biologics Inc. stock shows the strong sell signal. See more of HCW Biologics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.